BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

764 related articles for article (PubMed ID: 29858962)

  • 21. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.
    Chen L; Guo P; He Y; Chen Z; Chen L; Luo Y; Qi L; Liu Y; Wu Q; Cui Y; Fang F; Zhang X; Song T; Guo H
    Cell Death Dis; 2018 May; 9(5):513. PubMed ID: 29725020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G; Lin Y; Zhang H; Wu D
    Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.
    Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S
    DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma.
    Giannelli G; Bergamini C; Fransvea E; Sgarra C; Antonaci S
    Gastroenterology; 2005 Nov; 129(5):1375-83. PubMed ID: 16285938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of CD29-ILK-Akt signaling-mediated epithelial-mesenchymal transition of liver epithelial cells and chemoresistance and radioresistance in hepatocellular carcinoma cells.
    Jiang X; Wang J; Zhang K; Tang S; Ren C; Chen Y
    Med Oncol; 2015 May; 32(5):141. PubMed ID: 25805567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis.
    Yao Z; Xiong Z; Li R; Liang H; Jia C; Deng M
    Biomed Pharmacother; 2018 Aug; 104():102-109. PubMed ID: 29772429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cx32 reverses epithelial-mesenchymal transition in doxorubicin-resistant hepatocellular carcinoma.
    Yu M; Han G; Qi B; Wu X
    Oncol Rep; 2017 Apr; 37(4):2121-2128. PubMed ID: 28260043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
    Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
    J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma.
    Dai X; Ahn KS; Wang LZ; Kim C; Deivasigamni A; Arfuso F; Um JY; Kumar AP; Chang YC; Kumar D; Kundu GC; Magae J; Goh BC; Hui KM; Sethi G
    Mol Cancer Ther; 2016 Dec; 15(12):2966-2976. PubMed ID: 27765853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-transcription mediated Snail stabilization is involved in radiation exposure induced invasion and migration of hepatocarcinoma cells.
    Dong L; Zhang X; Xiang W; Ni J; Zhou W; Li H
    Biomed Pharmacother; 2018 Jul; 103():767-772. PubMed ID: 29684855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NKILA, a prognostic indicator, inhibits tumor metastasis by suppressing NF-κB/Slug mediated epithelial-mesenchymal transition in hepatocellular carcinoma.
    Chen R; Cheng Q; Owusu-Ansah KG; Song G; Jiang D; Zhou L; Xu X; Wu J; Zheng S
    Int J Biol Sci; 2020; 16(3):495-503. PubMed ID: 32015685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.
    Kim H; Choi GH; Na DC; Ahn EY; Kim GI; Lee JE; Cho JY; Yoo JE; Choi JS; Park YN
    Hepatology; 2011 Nov; 54(5):1707-17. PubMed ID: 22045674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.
    Song FN; Duan M; Liu LZ; Wang ZC; Shi JY; Yang LX; Zhou J; Fan J; Gao Q; Wang XY
    PLoS One; 2014; 9(9):e108507. PubMed ID: 25268581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
    Feng XJ; Pan Q; Wang SM; Pan YC; Wang Q; Zhang HH; Zhu MH; Zhang SH
    Tumour Biol; 2016 Aug; 37(8):11457-67. PubMed ID: 27010469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-surface Vimentin: A mislocalized protein for isolating csVimentin(+) CD133(-) novel stem-like hepatocellular carcinoma cells expressing EMT markers.
    Mitra A; Satelli A; Xia X; Cutrera J; Mishra L; Li S
    Int J Cancer; 2015 Jul; 137(2):491-6. PubMed ID: 25487874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HAb18G/CD147 is involved in TGF-β-induced epithelial-mesenchymal transition and hepatocellular carcinoma invasion.
    Ru NY; Wu J; Chen ZN; Bian H
    Cell Biol Int; 2015 Jan; 39(1):44-51. PubMed ID: 25044444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition.
    Lin CY; Tsai PH; Kandaswami CC; Lee PP; Huang CJ; Hwang JJ; Lee MT
    Cancer Sci; 2011 Apr; 102(4):815-27. PubMed ID: 21219539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
    Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
    Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.